A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period
Public ClinicalTrials.gov record NCT03116698. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Study to Evaluate the Dose-Response Relationship of the Efficacy and Safety of Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period.
Study identification
- NCT ID
- NCT03116698
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Dr. Reddy's Laboratories Limited
- Industry
- Enrollment
- 240 participants
Conditions and interventions
Conditions
Interventions
- Low dose DFD07 once daily Drug
- High dose DFD07 once daily Drug
- High dose DFD07 twice daily Drug
- Placebo twice daily Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 13, 2017
- Primary completion
- Nov 12, 2017
- Completion
- Jul 4, 2018
- Last update posted
- Apr 23, 2019
2017 – 2018
United States locations
- U.S. sites
- 20
- U.S. states
- 6
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigator Site 3 | Cerritos | California | 90703 | — |
| Investigator Site 1 | Fremont | California | 94538 | — |
| Investigator Site 9 | Palm Springs | California | 92262 | — |
| Investigator Site 18 | Santa Ana | California | 92701 | — |
| Investigator Site 16 | Boca Raton | Florida | 33486 | — |
| Investigator Site 8 | Lake City | Florida | 32055 | — |
| Investigator Site 7 | Miami | Florida | 33126 | — |
| Investigator Site 19 | Miami | Florida | 33162 | — |
| Investigator Site 20 | Miami Lakes | Florida | 33016 | — |
| Investigator Site 17 | Ormond Beach | Florida | 32174 | — |
| Investigator Site 6 | West Palm Beach | Florida | 33409 | — |
| Investigator Site 13 | Verona | New Jersey | 07044 | — |
| Investigator Site 15 | Stony Brook | New York | 11790 | — |
| Investigator Site 14 | Fort Washington | Pennsylvania | 19034 | — |
| Investigator Site 10 | Austin | Texas | 78660 | — |
| Investigator Site 4 | Houston | Texas | 77055 | — |
| Investigator Site 5 | Plano | Texas | 75024 | — |
| Investigator Site 11 | San Antonio | Texas | 78229 | — |
| Investigator Site 2 | San Antonio | Texas | 78229 | — |
| Investigator Site 12 | San Antonio | Texas | 78249 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03116698, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 23, 2019 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03116698 live on ClinicalTrials.gov.